Literature DB >> 6153628

Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.

T Arima, J Narumoto, H Shimomura, K Suwaki, K Kunishi, T Yasuhara, H Nagashima.   

Abstract

Serum Clq binding activity (ClqBA) is increased in diabetes mellitus with liver injury, carcinoma of gastrointestinal tract with metastatic liver and chronic liver disease (CLD). Significant elevations of ClqBA level are observed in the order of liver cirrhosis, chronic aggressive hepatitis and chronic persistent hepatitis. In CLD there are significant correlations between ClqBA and gamma-globulin, rheumatoid factor, anti-DNA-antibody, CH50, C3, C4, C3-activator and HBsAg.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6153628     DOI： 10.1007/BF02773701

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN： 0435-1339


  35 in total

1.  Discrepancy between Clq deviation and Raji cell tests in detection of circulating immune complexes in patients with leprosy.

Authors:  K S Tung; B Kim; B Bjorvatn; G Kronvall; L C McLaren; R C Williams
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

2.  Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells.

Authors:  I I Onyewotu; E J Holborow; G D Johnson
Journal:  Nature       Date:  1974-03-08       Impact factor: 49.962

3.  Serum immunoglobulins, complement component levels and autoantibodies in liver disease.

Authors:  R A Thompson; R Carter; R P Stokes; A M Geddes; J A Goodall
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

4.  Immune complexes in acute and chronic liver disease.

Authors:  H C Thomas; D De Villiers; B Potter; H Hodgson; S Jain; D P Jewell; S Sherlock
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

5.  C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types.

Authors:  V Agnello; D Koffler; J W Eisenberg; R J Winchester; H G Kundel
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

6.  Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.

Authors:  H S Luthra; F C McDuffie; G G Hunder; E A Samayoa
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

7.  The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.

Authors:  R D Rossen; M A Reisberg; E M Hersh; J U Gutterman
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

8.  Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.

Authors:  H Teshima; H Wanebo; C Pinsky; N K Day
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

9.  Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.

Authors:  T Arima; J Narumoto; H Shimomura; K Suwaki; K Kunishi; T Yasuhara; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1980

10.  Studies of urticaria and acute serum sickness with the C1q precipitin test.

Authors:  P Lieberman; M C Rice; J E Mallette
Journal:  Arch Intern Med       Date:  1977-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.